Investor's Business Daily on MSN

Catalyst Pharmaceuticals joins elite list of stocks with 95-plus composite rating

Catalyst Pharmaceuticals saw an improvement in its IBD SmartSelect Composite Rating Wednesday, from 94 to 96.
Zacks Investment Research on MSN

The Zacks rank explained: How to find strong buy medical stocks

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But what's the best way ...

Fidelity Disruptive Technology ETF Is Down 12% in 2026 and This Catalyst Could Decide What Comes Next

If you searched for a biotech or health sciences ETF and landed on Fidelity Disruptive Technology ETF (NYSEARCA:FDTX), there ...
24/7 Wall St.

United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo

United Therapeutics surged more than 12% in pre-market trading on March 30 after positive TETON-1 trial data triggered price ...

Cyclic catalysts use sunlight and air to regenerate during pharma ingredient synthesis

In chemical processes for producing pharmaceuticals, catalysts are a core technology that determines production speed and ...

Wall Street Analysts Predict a 45.3% Upside in Catalyst (CPRX): Here's What You Should Know

The mean of analysts' price targets for Catalyst (CPRX) points to a 45.3% upside in the stock. While this highly sought-after ...
The Manila Times

Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update

Company Highlights Commercial Launch of DARE to PLAY™ Sildenafil Cream, Pipeline of Women's Health Solutions, and Multiple ...